Haleon Announces the Launch of Eroxon®, The First and Only FDA Cleared OTC Gel for Erectile Dysfunction, Available for U.S. Preorder Without a Prescription

Core Insights - Eroxon® is the first and only FDA cleared over-the-counter gel for erectile dysfunction (ED) available without a prescription, now available for pre-order and set to launch in October 2024 [1][7] - Clinical studies demonstrate that Eroxon® is safe and effective, providing results within 10 minutes, addressing a significant unmet need compared to existing prescription solutions that may take up to an hour [2][3] Product Details - Eroxon® stimulates nerve endings in the penis to help men achieve and maintain an erection, enhancing intimacy and connection in relationships [3][4] - The application process involves massaging the gel onto the head of the penis, which can be done by the user or their partner as part of foreplay [4] Market Context - Erectile dysfunction affects approximately 30 million men in the U.S., with prevalence increasing with age; half of men over 40 experience ED [6] - Haleon aims to make Eroxon® accessible to millions of men affected by ED, emphasizing the importance of sexual health as part of overall wellness [4][8]